• Citer

Vorozole (R83842) in the treatment of postmenopausal advanced breast cancer: relationship of serum levels of vorozole and clinical results (a study of the EORTC Breast Cancer Cooperative Group).

par Bruning, Peter;Bonfrer, J M;Paridaens, R. ;Nooij, Marianne;Klijn, J G;Beex, Louk;Bruynseels, J;Piccart-Gebhart, Martine
Référence Anti-cancer drugs, 9, 5, page (419-425)
Publication Publié, 1998-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Vorozole (R83842) in the treatment of postmenopausal advanced breast cancer: relationship of serum levels of vorozole and clinical results (a study of the EORTC Breast Cancer Cooperative Group).
Auteur:	Bruning, Peter; Bonfrer, J M; Paridaens, R.; Nooij, Marianne; Klijn, J G; Beex, Louk; Bruynseels, J; Piccart-Gebhart, Martine
Informations sur la publication:	Anti-cancer drugs, 9, 5, page (419-425)
Statut de publication:	Publié, 1998-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- therapeutic use
	Breast Neoplasms -- drug therapy
	Female
	Hormones -- blood
	Humans
	Middle Aged
	Postmenopause
	Statistics as Topic
	Treatment Outcome
	Triazoles -- blood
	Triazoles -- therapeutic use
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
Langue:	Anglais
Identificateurs:	urn:issn:0959-4973
	info:pmid/9660539